The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.

You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.

Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.

How to search

The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.

To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.

You can also download an extract of all shortages and discontinuations.

To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.

Further information

Information about medicine shortages is available at the Medicine Shortages hub

Subscribe to Medicine Shortages updates

You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.


This service does not support Internet Explorer 7 and below.

Browse CRITICAL shortages and discontinuations

Click here to display ALL medicine shortages and discontinuations

fytic acid

calcium chloride dihydrate

potassium hydrogen phthalate

RADPHARM COLLOID kit for the preparation of Technetium(99mTc) calcium phytate injection composite pack

AUST R: 14332

Expected supply: 31 Dec 2026

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100

Updated: 02-01-2024


phenoxybenzamine hydrochloride

DIBENYLINE phenoxybenzamine hydrochloride 10mg capsule jar

AUST R: 12980

Expected supply: 30 Jun 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 21-06-2023


honey bee venom

ALBEY BEE VENOM honey bee venom 550 microgram powder for injection vial with 4 vials of Albumin saline diluent

AUST R: 161298

Expected supply: 31 May 2025

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 29-03-2023


Paper wasp venom

ALBEY PAPER WASP VENOM paper wasp venom 550 microgram powder for injection vial with 4 vials of Albumin saline diluent

AUST R: 18695

Expected supply: 31 May 2025

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 29-03-2023


Vespula spp venom

ALBEY YELLOW JACKET VENOM vespula spp venom 550 microgram powder for injection vial with 4 vials of Albumin Saline Diluent

AUST R: 18770

Expected supply: 31 May 2025

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 29-03-2023


Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)

ONCOTICE BCG 5 hundred million CFU powder for injection vial

AUST R: 59912

Expected supply: 31 Dec 2024

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 07-03-2022


bleomycin sulfate

CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial

AUST R: 220440

Expected supply: 31 Mar 2024

Availability: Unavailable

Management action: An alternative brand is available

Updated: 03-10-2023


amifostine

ETHYOL Amifostine (as trihydrate) 500mg powder for injection vial

AUST R: 63789

Expected supply: 31 Dec 2024

Availability: Unavailable

Management action: Alternative unapproved products available under the Special Access Scheme

Updated: 27-11-2023


tetracosactide

SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule

AUST R: 11060

Expected supply: 30 Nov 2026

Availability: Unavailable

Updated: 31-10-2023


hydralazine hydrochloride

HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial

AUST R: 272644

Expected supply: Unknown

Availability: Unavailable

Management action: Alternative brand available

Updated: 28-03-2023


voriconazole

VORCON voriconazole 200 mg powder for injection vial

AUST R: 235933

Expected supply: 30 Jun 2024

Availability: Unavailable

Management action: Alternative generic products are available.

Updated: 26-07-2023


activated charcoal

sorbitol

CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle

AUST R: 307429

Expected supply: 30 Apr 2024

Availability: Unavailable

Management action: Sponsor is working to expedite the next shipment.

Updated: 22-01-2024


dexamethasone sodium phosphate

DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 4mg/1mL (as sodium) injection ampoule

AUST R: 16374

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: An alternate presentation of the same strength is available.

Updated: 16-02-2023


adrenaline (epinephrine) acid tartrate

lidocaine hydrochloride

XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial

AUST R: 12008

Expected supply: 01 Apr 2024

Availability: Unavailable

Management action: Other strengths available.

Updated: 24-08-2023


imipramine hydrochloride

TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack

AUST R: 60673

Expected supply: 31 Dec 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient

Updated: 09-02-2024


hydrochlorothiazide

quinapril hydrochloride

ACCURETIC 10/12.5 tablet blister pack

AUST R: 81930

Expected supply: 30 Apr 2024

Availability: Unavailable

Updated: 17-03-2023


hydrochlorothiazide

quinapril hydrochloride

ACCURETIC 20/12.5 tablet blister pack

AUST R: 81931

Expected supply: 30 Apr 2024

Availability: Unavailable

Updated: 17-03-2023



Tenecteplase

METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe

AUST R: 75013

Expected supply: 31 Dec 2024

Availability: Limited Availability

Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of an additional 12 months from the original expiry date on the packaging for Metalyse batches with an original expiry date from January 2022 up to March 2025.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holders: Pro Pharmaceuticals Group Pty Ltd (Phone: 1300 077 674) or Medsurge Healthcare Pty Ltd (Phone: 1300 788 261).

Updated: 17-08-2023


vancomycin

DBL VANCOMYCIN vancomycin (as hydrochloride) 500mg powder for injection vial

AUST R: 62603

Expected supply: Unknown

Availability: Unavailable

Management action: An alternative brand is available

Updated: 21-11-2022


Alteplase

ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial

AUST R: 17905

Expected supply: 31 Dec 2024

Availability: Limited Availability

Updated: 19-10-2023


Alteplase

ACTILYSE alteplase (rch) 10mg powder for injection vial with water for injections 10mL vial

AUST R: 64240

Expected supply: 31 Dec 2024

Availability: Limited Availability

Updated: 19-10-2023


methylene blue

Phebra METHYLENE BLUE 50 mg/5 mL injection vial

AUST R: 223583

Expected supply: 22 Feb 2024

Availability: Available

Updated: 22-02-2024


ciprofloxacin

DBL CIPROFLOXACIN 200 mg/100 mL injection for intravenous infusion bag

AUST R: 123041

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: Alternative generic product is available

Updated: 11-09-2023


ciprofloxacin

DBL CIPROFLOXACIN 400 mg/200 mL injection for intravenous infusion bag

AUST R: 123042

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Updated: 19-01-2024


gemtuzumab ozogamicin

MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial

AUST R: 316671

Expected supply: 26 Dec 2022

Availability: Available

Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.

Updated: 03-11-2022


heparin sodium

HEPARIN SODIUM 5000IU/5mL (porcine mucous) injection ampoule

AUST R: 49232

Expected supply: 28 Jun 2024

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Orspec Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.

Updated: 08-02-2024


vancomycin

DBL VANCOMYCIN vancomycin (as hydrochloride) 1000 mg powder for injection vial

AUST R: 62595

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: An alternative brand is available

Updated: 14-12-2022


suxamethonium chloride dihydrate

SUXAMETHONIUM JUNO suxamethonium chloride dihydrate 100 mg/2 mL injection ampoule

AUST R: 320687

Expected supply: 01 May 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 05-12-2023


dobutamine hydrochloride

DBL DOBUTAMINE 250mg/20mL (as hydrochloride) injection vial

AUST R: 46451

Expected supply: 26 Apr 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 06-02-2024


piperacillin sodium

tazobactam sodium

TAZOPIP 4 g/0.5 g piperacillin (as sodium) 4 g and tazobactam (as sodium) 0.5 g powder for injection vial

AUST R: 144970

Expected supply: 31 Dec 2024

Availability: Unavailable

Management action: Other brands are available.

Updated: 11-08-2023


sodium nitrite

HOPE PHARMACEUTICALS SODIUM NITRITE INJECTION sodium nitrite 300 mg/10 mL solution for injection vial

AUST R: 276671

Expected supply: 30 Apr 2024

Availability: Unavailable

Management action: An alternative brand is available

Updated: 18-03-2024


calcium folinate

DBL LEUCOVORIN CALCIUM folinic acid 300 mg/30 mL (as calcium folinate) injection vial

AUST R: 116688

Expected supply: 05 Apr 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.

Updated: 30-01-2024


sodium thiosulfate pentahydrate

DBL SODIUM THIOSULFATE INJECTION sodium thiosulfate pentahydrate 2.5g/10mL solution for injection vial

AUST R: 133490

Expected supply: 05 Apr 2024

Availability: Limited Availability

Management action: Alternative generic product is available.

Updated: 05-12-2023


cilastatin

imipenem

PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial

AUST R: 10509

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Updated: 06-02-2024


aciclovir

DBL Aciclovir 500mg/20mL Intravenous infusion injection vial

AUST R: 56810

Expected supply: 12 Apr 2024

Availability: Unavailable

Management action: Alternative brands and strengths available.

Updated: 17-11-2023


amikacin

DBL AMIKACIN 500mg/2mL (as sulfate) injection vial

AUST R: 49945

Expected supply: 28 Jun 2024

Availability: Unavailable

Management action: Alternative generic products are available

Updated: 22-02-2024


ampicillin

IBIMICYN ampicillin 1g (as sodium) powder for injection vial

AUST R: 92840

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 27-09-2023



aciclovir

DBL Aciclovir 250mg/10mL Intravenous infusion injection vial

AUST R: 56809

Expected supply: 31 Oct 2024

Availability: Unavailable

Management action: The sponsor is working to expedite the next shipment. Alternative generic products are available.

Updated: 28-02-2024



amikacin sulfate

AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial

AUST R: 288798

Expected supply: 30 Jun 2024

Availability: Unavailable

Management action: Alternative generic products are available

Updated: 13-10-2023


ampicillin

IBIMICYN ampicillin 500mg (as sodium) powder for injection vial

AUST R: 92839

Expected supply: 12 Mar 2024

Availability: Available

Updated: 12-03-2024


ethosuximide

ZARONTIN ethosuximide 250mg capsule bottle

AUST R: 94175

Expected supply: 31 Jul 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 28-02-2024


morphine sulfate pentahydrate

DBL MORPHINE SULFATE 15mg/1mL injection ampoule

AUST R: 101243

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: Alternative generic products are available and other strengths are available.

Updated: 27-09-2023


benzathine benzylpenicillin tetrahydrate

BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle

AUST R: 147169

Expected supply: 28 Jun 2024

Availability: Limited Availability

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder ORSPEC Pharma Pty Ltd can be contacted on 02 4339 4239 for details on supply.

Pfizer are closely controlling supply and pharmacies can contact 1800 629 921 for ordering enquiries.

A TGA web alert is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-bicillin-l-benzathine-benzylpenicillin-tetrahydrate-prefilled-syringe-injection

Updated: 29-01-2024


rifampicin

RIFADIN rifampicin 300mg capsules blister pack

AUST R: 233443

Expected supply: 30 Apr 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder Sanofi-Aventis Australia Pty Ltd can be contacted on 1800818806 for details on supply.

Updated: 09-02-2024


voriconazole

VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial

AUST R: 267013

Expected supply: 01 Jun 2024

Availability: Unavailable

Management action: Alternative generic products are available

Updated: 13-10-2023



calcium folinate

Pfizer (Australia) LEUCOVORIN CALCIUM folinic acid (as calcium folinate) 100mg/10mL injection USP ampoule

AUST R: 61887

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: Other strengths are available

Updated: 02-02-2024


heparin sodium

HEPARINISED SALINE 50IU/5mL (porcine mucous) injection ampoule

AUST R: 66684

Expected supply: 08 Jan 2024

Availability: Available

Updated: 08-01-2024


sodium nitrite

DBL SODIUM NITRITE 0.3g/10mL injection BPC ampoule

AUST R: 16290

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: An alternative brand is available.

Updated: 27-10-2023


bleomycin sulfate

DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial

AUST R: 42569

Expected supply: 15 Mar 2024

Availability: Available

Updated: 15-03-2024


noradrenaline (norepinephrine) acid tartrate monohydrate

NORADRENALINE MEDSURGE noradrenaline (norepinephrine) (as acid tartrate monohydrate) 2 mg/2 mL concentrated injection ampoule

AUST R: 349471

Expected supply: 29 Mar 2024

Availability: Unavailable

Management action: Sponsor working to expedite next shipment. Alternative generic product is available

Updated: 08-03-2024


calcium folinate

DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)

AUST R: 42148

Expected supply: 31 May 2024

Availability: Unavailable

Management action: Alternate product available via Special Access Scheme (SAS).

Updated: 13-02-2024


rifampicin

RIMYCIN 150 rifampicin 150 mg capsule bottle

AUST R: 48230

Expected supply: 30 Apr 2024

Availability: Unavailable

Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. The approval holder Sanofi-Aventis Australia Pty Ltd can be contacted on 1800818806 for details on supply.

Updated: 19-03-2024


rifampicin

RIFADIN rifampicin 150mg capsules blister pack

AUST R: 233442

Expected supply: 14 Mar 2024

Availability: Available

Updated: 15-03-2024


magnesium sulfate heptahydrate

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 2.47g/5mL injection ampoule

AUST R: 16311

Expected supply: 09 Feb 2024

Availability: Available

Updated: 12-02-2024


silver sulfadiazine

FLAMAZINE silver sulfadiazine 1.0% w/w cream jar

AUST R: 159338

Expected supply: 31 Mar 2024

Availability: Unavailable

Management action: The TGA is in consultation with the sponsor to develop a management strategy.

Updated: 01-03-2024



silver sulfadiazine

FLAMAZINE silver sulfadiazine 1.0% w/w cream tube

AUST R: 159342

Expected supply: 31 Mar 2024

Availability: Unavailable

Updated: 01-03-2024


ethambutol hydrochloride

ETHAMBUTOL LUPIN ethambutol hydrochloride 400 mg tablet bottle

AUST R: 365231

Expected supply: 12 Apr 2024

Availability: Unavailable

Management action: The sponsor is working to expedite the next shipment. Alternative generic products are available.

Updated: 23-02-2024


sodium oxidronate

TECHNESCAN HDP kit for preparation of Technetium [99mTc] oxidronate powder for injection vial

AUST R: 75500

Expected supply: 30 Jun 2024

Availability: Unavailable

Management action: An unregistered product has been approved for supply under Section 19A. The approval holder Landauer Radiopharmaceuticals Pty Ltd can be contacted on 02 8651 4000 for details on supply.

Updated: 09-02-2024


calcium folinate

Pfizer (Australia) LEUCOVORIN CALCIUM folinic acid (as calcium folinate) 50mg/5mL injection USP ampoule

AUST R: 61885

Expected supply: 05 Apr 2024

Availability: Limited Availability

Management action: The sponsor is closely controlling the supply.
Alternate product available via Special Access Scheme (SAS).

Updated: 13-02-2024


methoxyflurane

PENTHROX methoxyflurane inhalation bottle

AUST R: 43144

Expected supply: 20 Feb 2024

Availability: Available

Updated: 21-02-2024


carmustine

GLIADEL WAFER carmustine 7.7mg/implant implant sachet

AUST R: 77283

Expected supply: Unknown

Availability: Reduction in supply until supply is exhausted

Management action: An alternative unapproved product may be available under the Special Access Scheme (SAS). For further information about SAS please see https://www.tga.gov.au/form/special-access-scheme

Updated: 07-03-2024


naloxone hydrochloride dihydrate

NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial

AUST R: 309381

Expected supply: 19 Apr 2024

Availability: Emergency Supply Only

Management action: Other dosage forms are available. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

Updated: 11-03-2024


sodium pyrophosphate

RADPHARM PYP kit for the preparation of Technetium (99mTc) tin pyrophosphate powder for injection multidose vial

AUST R: 14328

Expected supply: 03 Jun 2024

Availability: Unavailable

Management action: The sponsor is working to expedite next shipment.

Updated: 15-03-2024


hydrocortisone sodium succinate

SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 250mg powder for injection and diluent dual-chamber vial

AUST R: 167894

Expected supply: 10 May 2024

Availability: Limited Availability

Management action: Alternative products in a different dosage strength are available.

Updated: 28-02-2024


rifampicin

RIMYCIN 300 rifampicin 300 mg capsule bottle

AUST R: 48231

Expected supply: 12 Apr 2024

Availability: Limited Availability

Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. The approval holder Sanofi-Aventis Australia Pty Ltd can be contacted on 1800818806 for details on supply.

Updated: 04-03-2024


Vibrio cholerae

Vaxchora Vibrio cholerae bacteria cells (CVD 103-HgR strain) 4 x 10^8 to 2 x 10^9 CFU suspension, powder for, sachet

AUST R: 389746

Expected supply: 30 Apr 2024

Availability: Available

Management action: Sponsor is working to expedite the next shipment.
Supply of an overseas registered product is being consider under Section s19A.

Updated: 14-03-2024


ampicillin

AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial

AUST R: 29354

Expected supply: 30 May 2024

Availability: Available

Management action: The sponsor is closely controlling the supply.

Updated: 15-03-2024


raltitrexed

TOMUDEX raltitrexed 2mg powder for injection vial

AUST R: 54638

Expected supply: 21 Jun 2024

Availability: Available

Management action: The sponsor is closely controlling the supply and is working to expedite the next shipment.

Updated: 15-03-2024


Enter an active ingredient or trade name

{{headingLabels[selectedTab]}}

Sort by: Updated date | Active ingredient | Trade name | Therapeutic class

{{atc}}

No {{headingLabels[status].toLowerCase()}} found.

  • View

URL: http://apps.tga.gov.au/prod/MSI/search/